EXPERIENCE WITH A SLOW-RELEASE FORMULATION OF OXPRENOLOL

被引：0
|
作者：
WAALMANNING, HJ [1 ]
SPEARS, GFS [1 ]
机构：
[1] UNIV OTAGO,SCH MED,DEPT PREVENT & SOC MED,DUNEDIN,NEW ZEALAND
来源：
NEW ZEALAND MEDICAL JOURNAL | 1978年 / 87卷 / 609期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：245 / 246
页数：2
相关论文
共 50 条
  • [31] INFLUENCE OF GRAPEFRUIT JUICE ON THE PHARMACOKINETICS OF A SLOW-RELEASE NIFEDIPINE FORMULATION
    SIGUSCH, H
    HIPPIUS, M
    HENSCHEL, L
    KAUFMANN, K
    HOFFMANN, A
    PHARMAZIE, 1994, 49 (07): : 522 - 524
  • [32] ANTIHYPERTENSIVE EFFECT OF A NEW FORMULATION OF SLOW RELEASE OXPRENOLOL IN ESSENTIAL-HYPERTENSION
    POMIDOSSI, G
    PARATI, G
    MALASPINA, D
    CAMESASCA, C
    MOTOLESE, M
    ZANCHETTI, A
    MANCIA, G
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1987, 10 (05) : 593 - 598
  • [33] PHARMACODYNAMIC AND PHARMACOKINETIC STUDY OF A SLOW-RELEASE FORMULATION OF FUROSEMIDE IN MAN
    EBIHARA, A
    TAWARA, K
    OKA, T
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1983, 33-1 (01): : 163 - 166
  • [34] THE EFFECT OF CATHARTICS ON DRUG ABSORPTION FROM A SLOW-RELEASE FORMULATION
    MASSANARI, M
    HENDELES, L
    NEIMS, A
    POHORYLO, E
    GEORGE, D
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1985, 19 (06): : 462 - 462
  • [35] TREATMENT OF ESSENTIAL ARTERIAL-HYPERTENSION WITH OXPRENOLOL AND CHLORTALIDONE - IMPORTANCE OF A SLOW-RELEASE PREPARATION (SR)
    DIVAN, S
    TOSCANODAGRACA, CA
    RIBAMARDIASCARNEIRO, JD
    REVISTA BRASILEIRA DE MEDICINA, 1979, 36 (10) : 511 - 517
  • [36] A FIXED COMBINATION OF OXPRENOLOL SLOW-RELEASE AND CHLORTHALIDONE ONCE DAILY IN TREATMENT OF MILD TO MODERATE HYPERTENSION
    MUIESAN, G
    AGABITIROSEI, E
    BUONINCONTI, R
    CAROTTI, A
    FARIELLO, R
    INNOCENTI, P
    TOSO, M
    VALORI, C
    MOTOLESE, M
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1981, 19 (06) : 249 - 255
  • [37] PHARMACOKINETIC AND PHARMACODYNAMIC COMPARISON OF A NEW CONTROLLED-RELEASE FORMULATION OF METOPROLOL WITH A TRADITIONAL SLOW-RELEASE FORMULATION
    OOSTERHUIS, B
    JONKMAN, JHG
    KERKHOF, FA
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 33 : S15 - S18
  • [38] COMPARISON OF SLOW RELEASE OXPRENOLOL WITH CONVENTIONAL OXPRENOLOL IN TREATMENT OF HYPERTENSION
    RESNEKOV, EB
    HAVARD, CWH
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 14 (02) : 77 - 81
  • [39] COMPARISON OF SLOW-RELEASE SALBUTAMOL WITH SLOW-RELEASE AMINOPHYLLINE IN NOCTURNAL ASTHMA
    MILLEDGE, JS
    MORRIS, J
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1979, 7 : 106 - 110
  • [40] Laser-ablated nanofunctional polymers for the formulation of slow-release powders for dry powder inhalers: physicochemical characterization and slow-release characteristics
    Coowanitwong, Intira
    Arya, Vikram
    Patel, Gina
    Kim, Won-Seok
    Craciun, Valentin
    Rocca, James R.
    Hochhaus, Guenther
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2007, 59 (11) : 1473 - 1484
12345